Wisconsin Diagnostic Laboratories LLC

Wisconsin Diagnostic Laboratories LLC was paid $22.72M by Medicaid between Jan 2018 and Dec 2024, across 253 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 19% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Wisconsin

Rank by total paid#3 of 75

Median peer was paid$106K

This provider vs. median214×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	129,901	$1.98M
2019	217,005	$2.77M
2020	207,884	$3.60M
2021	216,056	$4.47M
2022	212,125	$3.76M
2023	200,580	$3.12M
2024incomplete	197,851	$3.02M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	19%	58,533	51,396	$4.33M
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	7.1%	57,944	52,875	$1.62M
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	6.5%	52,929	49,287	$1.47M
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	5.6%	14,062	12,815	$1.27M
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	3.2%	29,257	27,079	$725K
81420	Fetal chromosomal aneuploidy genomic sequence analysis panel	3.1%	1,610	1,480	$711K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	2.3%	27,267	25,364	$519K
86481		2.0%	6,823	6,275	$456K
80061	Lipid panel	1.9%	43,875	40,886	$433K
87536		1.9%	5,939	5,469	$430K
80053	Comprehensive metabolic panel	1.8%	52,285	45,120	$403K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	1.7%	28,554	25,700	$386K

241 more codes

86480		1.7%	7,353	$379K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	1.6%	12,033	$372K
80050	General health panel	1.5%	9,565	$351K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	1.5%	17,400	$349K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	1.5%	12,369	$336K
84443	Thyroid stimulating hormone (TSH)	1.4%	28,033	$324K
83655		1.4%	29,759	$321K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	1.3%	54,348	$300K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	1.3%	2,931	$298K
86803		1.2%	24,970	$268K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	1.1%	6,876	$246K
G0145	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision	1.1%	12,713	$244K
80048	Basic metabolic panel (calcium, ionized)	<1%	37,944	$224K
83036	Hemoglobin; glycosylated (A1C)	<1%	33,305	$223K
87529		<1%	7,709	$210K
87086	Culture, bacterial; quantitative colony count, urine	<1%	31,739	$197K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	1,149	$189K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	4,868	$187K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	2,541	$169K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	8,170	$166K
80081		<1%	2,961	$158K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	6,116	$150K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	5,019	$137K
87077		<1%	17,534	$130K
82728		<1%	11,600	$119K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	4,822	$109K
85027		<1%	20,915	$105K
82607		<1%	10,098	$104K
87088		<1%	16,378	$104K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	2,346	$104K
86592		<1%	30,767	$103K
86360		<1%	2,494	$102K
87186		<1%	12,722	$86K
84403		<1%	4,618	$84K
83013		<1%	1,656	$82K
87522	Neg quan hep c or qual rna	<1%	2,615	$81K
86359		<1%	2,497	$79K
83970		<1%	3,218	$79K
87340		<1%	10,360	$79K
81329		<1%	1,010	$74K
86762		<1%	6,473	$69K
85018		<1%	30,595	$66K
84439		<1%	9,676	$66K
80074		<1%	2,304	$58K
84146		<1%	3,921	$58K
83516		<1%	6,180	$57K
83880		<1%	2,395	$56K
82746		<1%	5,362	$54K
84702		<1%	4,594	$53K
83001		<1%	3,832	$51K
82670		<1%	2,836	$50K
82951		<1%	3,941	$46K
85610		<1%	15,274	$46K
87081		<1%	8,122	$45K
86038		<1%	4,637	$42K
83550		<1%	6,623	$42K
83735		<1%	7,945	$38K
83540		<1%	7,962	$38K
87563		<1%	2,048	$37K
87210		<1%	9,326	$37K
82043		<1%	9,473	$37K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	1,225	$35K
86140		<1%	8,931	$35K
86706		<1%	4,309	$35K
87070		<1%	5,193	$35K
87493		<1%	1,446	$35K
83021		<1%	2,430	$35K
87631		<1%	360	$33K
80076		<1%	5,268	$32K
81001		<1%	13,575	$31K
84481		<1%	2,749	$31K
86618		<1%	2,071	$31K
82274		<1%	2,386	$29K
99001		<1%	9,382	$29K
86850		<1%	6,771	$28K
86003		<1%	1,050	$28K
82105		<1%	2,340	$27K
80197		<1%	3,004	$26K
86696		<1%	1,613	$25K
86787		<1%	3,167	$25K
80164		<1%	2,392	$24K
84460		<1%	5,172	$24K
83002		<1%	1,783	$23K
82533		<1%	1,969	$21K
82627		<1%	1,510	$20K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	974	$19K
G0472	Hepatitis c antibody screening, for individual at high risk and other covered indication(s)	<1%	6,098	$18K
84153		<1%	1,599	$18K
82677		<1%	1,008	$18K
82024		<1%	731	$17K
82950		<1%	4,216	$17K
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	1,300	$17K
84100		<1%	4,573	$17K
83525		<1%	2,006	$16K
86695		<1%	1,345	$16K
86376		<1%	1,626	$15K
86780		<1%	1,730	$15K
87450		<1%	1,852	$15K
86900		<1%	6,613	$14K
86901		<1%	6,198	$14K
82784		<1%	1,781	$13K
86336		<1%	1,003	$13K
87521	Neg quan hep c or qual rna	<1%	572	$13K
86431		<1%	2,953	$12K
87902		<1%	61	$12K
82652		<1%	634	$12K
86235		<1%	851	$12K
86160		<1%	1,102	$11K
88112		<1%	341	$11K
87338		<1%	911	$11K
87209		<1%	845	$11K
86704		<1%	1,198	$11K
86800		<1%	1,059	$11K
83090		<1%	880	$10K
83690		<1%	2,006	$10K
87046		<1%	1,435	$10K
86765		<1%	1,167	$10K
86735		<1%	914	$10K
87045		<1%	1,431	$10K
84270		<1%	742	$10K
82947		<1%	3,072	$10K
87205		<1%	3,014	$10K
84550		<1%	2,987	$10K
82565		<1%	2,650	$10K
86705		<1%	1,178	$10K
82570		<1%	2,408	$9K
87634		<1%	249	$9K
80055		<1%	509	$9K
82550		<1%	1,845	$9K
85652		<1%	4,286	$8K
86708		<1%	787	$8K
86769		<1%	307	$8K
84402		<1%	484	$8K
87808		<1%	794	$7K
84450		<1%	1,727	$7K
86694		<1%	553	$7K
86200		<1%	846	$7K
84425		<1%	608	$7K
86225		<1%	763	$7K
82248		<1%	1,563	$6K
86334		<1%	492	$6K
84156		<1%	2,308	$6K
82785		<1%	745	$6K
85730		<1%	1,251	$6K
83520		<1%	560	$5K
85045		<1%	1,806	$5K
87177		<1%	814	$5K
80178		<1%	1,062	$5K
84165		<1%	754	$5K
80165		<1%	559	$5K
36415	Collection of venous blood by venipuncture	<1%	87,356	$5K
85651		<1%	1,494	$5K
83993		<1%	343	$4K
83014		<1%	631	$4K
82330		<1%	425	$4K
86593		<1%	1,033	$4K
87101		<1%	420	$3K
87206		<1%	649	$3K
83498		<1%	180	$3K
82977		<1%	489	$3K
87632		<1%	15	$3K
87901		<1%	12	$3K
85007		<1%	1,029	$3K
P9603	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled	<1%	10,059	$3K
86709		<1%	334	$3K
82465		<1%	588	$2K
87106		<1%	302	$2K
82140		<1%	208	$2K
82247		<1%	512	$2K
84144		<1%	186	$2K
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	<1%	7,843	$2K
80202		<1%	146	$2K
82952		<1%	619	$2K
87147		<1%	460	$2K
84132		<1%	482	$2K
G0471	Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha)	<1%	5,290	$2K
G0432	Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening	<1%	11,383	$2K
88342		<1%	105	$2K
G0476	Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test	<1%	1,669	$2K
87497		<1%	64	$2K
87900		<1%	12	$2K
G0123	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision	<1%	77	$1K
87427		<1%	98	$1K
82150		<1%	223	$1K
84154		<1%	79	$993.22
84630		<1%	167	$935.58
84134		<1%	150	$912.33
87184		<1%	158	$898.12
82239		<1%	89	$838.79
83615		<1%	178	$774.55
80175		<1%	65	$699.52
84480		<1%	59	$652.81
87107		<1%	48	$641.21
85246		<1%	24	$500.43
82610		<1%	42	$496.67
84145		<1%	25	$495.64
0352U		<1%	597	$490.38
87269		<1%	43	$487.73
83921		<1%	49	$474.30
88304		<1%	34	$467.43
86870		<1%	13	$426.95
83721		<1%	58	$422.61
87593		<1%	15	$406.40
84436		<1%	95	$398.50
80177		<1%	41	$391.18
84445		<1%	13	$387.54
87272		<1%	31	$383.88
82088		<1%	14	$365.50
87799		<1%	15	$348.55
83521		<1%	25	$336.44
86677		<1%	48	$309.20
84478		<1%	63	$297.20
87075		<1%	41	$250.02
85014		<1%	145	$239.38
84080		<1%	35	$237.12
85245		<1%	12	$234.78
85247		<1%	12	$234.78
85240		<1%	24	$228.66
86039		<1%	32	$223.76
87350		<1%	20	$219.07
85379		<1%	30	$191.18
81025		<1%	27	$163.23
84207		<1%	15	$161.70
84202		<1%	14	$160.14
83010		<1%	20	$156.30
82166		<1%	84	$122.12
84466		<1%	13	$121.14
87328		<1%	13	$121.04
84075		<1%	38	$109.00
87329		<1%	13	$106.49
85004		<1%	14	$103.71
86255		<1%	28	$97.61
G0328	Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous	<1%	151	$95.31
80156		<1%	14	$90.35
82040		<1%	29	$73.77
85660		<1%	14	$57.29
G0499	Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result	<1%	149	$56.93
86880		<1%	13	$54.76
82525		<1%	12	$44.43
G0124	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician	<1%	339	$21.86
G0466	Community health center visit, new patient	0%	127	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHERBNER, ROBIN (CFO)